were low LVEF meeting inversion-recovery gradient-echo all-cause mortality risk of bias age = 65.3 ± 10.9 years; criteria for an ICD; mild LV sequence appropriate ICD discharge male = 74%; dysfunction with palpitations, SCD Contrast agent: 0.15 mmol/kg frequent premature cardiac death NYHA class: I = 29%, II = gadoversetamide ventricular contractions, VF/VT events 29%, III = 36%, IV = 7%; and/or non-sustained VT; hospitalisation for CHF Time delay: 10 minutes LVEF (CMR) = 30.5 ± 14.0%; evaluation of wide-complex ICD implantation LV function: LV volumes, mass, tachycardia; syncope; and QRS interval = 115.2 ± and LVEF were quantitatively in LGE+ patients compared with those presumed cardiac arrest. 30.3 milliseconds; that are LGE–, and in NIDCM patients measured from the stack of Exclusion criteria: patients compared with ICM patients cine images using standard LBBB = 15%; with contraindications for techniques. RBBB = 14%; CMR (prior pacemaker or LGE diagnosis: LGE assessment defibrillator) or under medications: ACE inhibitor = was masked to all patient 18 years of age 66%, ARB = 12%, information by a single reader. -blockers = 78% Regional enhancement was scored according to the spatial N=64 patients without CAD: extent of LGE+ tissue within each n=37 (58%) LGE+ segment 0 = no LGE, 1 = 1–25%, n=27 (42%) LGE– 2 = 26–50%, 3 = 51–75%, 4 = LGE Patient characteristics: age = 52.3 ± 16.2 years; male = 50%; NYHA class: I = 47%, II = 20%, III = 27%, IV = 3%; LVEF (CMR) = 40.9 ± 20.6%; QRS interval = 108.3 ± 33.2 milliseconds; LBBB = 16%;
risk of bias age = 65.3 ± 10.9 years; male = 74%; NYHA class: I = 29%, II = 29%, III = 36%, IV = 7%; LVEF (CMR) = 30.5 ± 14.0%; QRS interval = 115.2 ± 30.3 milliseconds; LBBB = 15%; RBBB = 14%; medications: ACE inhibitor = 66%, ARB = 12%, -blockers = 78% N=64 patients without CAD: n=37 (58%) LGE+ n=27 (42%) LGE– Patient characteristics: age = 52.3 ± 16.2 years; male = 50%; NYHA class: I = 47%, II = 20%, III = 27%, IV = 3%; LVEF (CMR) = 40.9 ± 20.6%; QRS interval = 108.3 ± 33.2 milliseconds; LBBB = 16%; were low LVEF meeting criteria for an ICD; mild LV dysfunction with palpitations, frequent premature ventricular contractions, and/or non-sustained VT; evaluation of wide-complex tachycardia; syncope; and presumed cardiac arrest. Exclusion criteria: patients with contraindications for CMR (prior pacemaker or defibrillator) or under 18 years of age inversion-recovery gradient-echo sequence Contrast agent: 0.15 mmol/kg gadoversetamide Time delay: 10 minutes LV function: LV volumes, mass, and LVEF were quantitatively measured from the stack of cine images using standard techniques. LGE diagnosis: LGE assessment was masked to all patient information by a single reader. Regional enhancement was scored according to the spatial extent of LGE+ tissue within each segment 0 = no LGE, 1 = 1–25%, 2 = 26–50%, 3 = 51–75%, 4 = LGE all-cause mortality appropriate ICD discharge SCD cardiac death VF/VT events hospitalisation for CHF ICD implantation in LGE+ patients compared with those that are LGE–, and in NIDCM patients compared with ICM patients